Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New appointment at TranScrip Partners

This article was originally published in Scrip

Executive Summary

TranScrip Partners (UK), a pharmaceutical development firm that provides advice and support to pharmaceutical and biotechnology companies, has appointed Gareth Walters partner. He has more than 20 years' experience in regulatory affairs, clinical research and product management, having most recently served as regional director of medicines development for Europe and the US at Choice Pharma. Mr Walters has also served as project leader of global regulatory affairs at Roche. After that, he joined the founding management team of Protigm, a drug development company and Roche subsidiary, which subsequently became Fulcrum Pharma.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel